| ||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Search results for: "M"
Results 41 - 50 of 604 shown below 
|
||||||||
|
||||||||
|
||||||||
|
||||||||
| malignant germ cell tumour D A Anthoney, M J McKean, J T Roberts, A W Hutcheon, J Graham, W Jones, J Paul and S B Kaye Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours doi:10.1038/sj.bjc.6601528 Abstract | Full article | PDF |
||||||||
| malignant germ cell tumours S D Fosså, N Aass, S Harvei and S Tretli Increased mortality rates in young and middle-aged patients with malignant germ cell tumours doi:10.1038/sj.bjc.6601558 Abstract | Full article | PDF |
||||||||
| malignant glioma M R Graf, W Jia and R M Loria The neuro-steroid, 3  androstene 17 diol exhibits potent cytotoxic effects on human malignant glioma and lymphoma cells through different programmed cell death pathways
advance online publication, 2007-07-17 00:00:00.000; doi:10.1038/sj.bjc.6603894 Abstract | Full article | PDF T Saito, S Hama, H Izumi, F Yamasaki, Y Kajiwara, S Matsuura, K Morishima, T Hidaka, P Shrestha, K Sugiyama and K Kurisu Centrosome amplification induced by survivin suppression enhances both chromosome instability and radiosensitivity in glioma cells advance online publication, 2008-01-15 00:00:00.000; doi:10.1038/sj.bjc.6604160 Abstract | Full article | PDF K Kohshi, Y Kinoshita, H Imada, N Kunugita, H Abe, H Terashima, N Tokui and S Uemura Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas doi:10.1038/sj.bjc.6690345 Abstract | Full article | PDF W K A Yung, R E Albright, J Olson, R Fredericks, K Fink, M D Prados, M Brada, A Spence, R J Hohl, W Shapiro, M Glantz, H Greenberg, R G Selker, N A Vick, R Rampling, H Friedman, P Phillips, J Bruner, N Yue, D Osoba, S Zaknoen and V A Levin A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse doi:10.1054/bjoc.2000.1316 Abstract | Full article | PDF |
||||||||
| malignant gliomas A Yannopoulos, E Dimitriadis, A Scorilas, T Trangas, E Markakis and M Talieri mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete advance online publication, 2005-06-28 00:00:00.000; doi:10.1038/sj.bjc.6602642 Abstract | Full article | PDF |
||||||||
| malignant lymphoma M Mohren, I Markmann, K Jentsch-Ullrich, M Koenigsmann, G Lutze and A Franke Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis advance online publication, 2005-03-29 00:00:00.000; doi:10.1038/sj.bjc.6602504 Abstract | Full article | PDF A Okines, C S Thomson, C R Radstone, J M Horsman and B W Hancock Second primary malignancies after treatment for malignant lymphoma doi:10.1038/sj.bjc.6602731 Abstract | Full article | PDF K Remes, K-F Norrback, R Rosenquist, C Mehle, J Lindh and G Roos Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse doi:10.1054/bjoc.1999.0970 Abstract | Full article | PDF |
||||||||
| malignant melanoma U Hofmann, M Szedlak, W Rittgen, E G Jung and D Schadendorf Primary staging and follow-up in melanoma patients – monocenter evaluation of methods, costs and patient survival doi:10.1038/sj.bjc.6600428 Abstract | Full article | PDF D B McKenna, D Stockton, D H Brewster and V R Doherty Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland doi:10.1038/sj.bjc.6600692 Abstract | Full article | PDF G C de Gast, D Batchelor, M J Kersten, F A Vyth-Dreese, J Sein, W F van de Kasteele, W J Nooijen, O E Nieweg, M A de Waal and W Boogerd Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN in patients with metastatic melanoma
doi:10.1038/sj.bjc.6600717 Abstract | Full article | PDF M Lambe, P Blomqvist and R Bellocco Seasonal variation in the diagnosis of cancer: a study based on national cancer registration in Sweden doi:10.1038/sj.bjc.6600901 Abstract | Full article | PDF J D Shields, M Borsetti, H Rigby, S J Harper, P S Mortimer, J R Levick, A Orlando and D O Bates Lymphatic density and metastatic spread in human malignant melanoma doi:10.1038/sj.bjc.6601571 Abstract | Full article | PDF R M MacKie and C A Bray Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma doi:10.1038/sj.bjc.6601595 Abstract | Full article | PDF J H Olsen, S Friis, K Frederiksen, J K McLaughlin, L Mellemkjaer and H Møller Atypical cancer pattern in patients with Parkinson's disease advance online publication, 2004-12-07 00:00:00.000; doi:10.1038/sj.bjc.6602279 Abstract | Full article | PDF A Downing, J A Newton-Bishop and D Forman Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993–2003 advance online publication, 2006-06-06 00:00:00.000; doi:10.1038/sj.bjc.6603216 Abstract | Full article | PDF M Mowbray, D L Stockton and V R Doherty Changes in the site distribution of malignant melanoma in South East Scotland (1979–2002) advance online publication, 2007-02-13 00:00:00.000; doi:10.1038/sj.bjc.6603612 Abstract | Full article | PDF M Fojtova, V Boudny, A Kovarik, L Lauerova, L Adamkova, K Souckova, J Jarkovsky and J Kovarik Development of IFN-  resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells
advance online publication, 2007-06-19 00:00:00.000; doi:10.1038/sj.bjc.6603849 Abstract | Full article | PDF A Thies, P Dautel, A Meyer, U Pfüller and U Schumacher Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model advance online publication, 2007-11-20 00:00:00.000; doi:10.1038/sj.bjc.6604106 Abstract | Full article | PDF J M Karjalainen, M Reinikainen and V-M Kosma p21WAF1/CIP1expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival doi:10.1038/sj.bjc.6690143 Abstract | Full article | PDF M Deichmann, M Thome, M Bock, A Jäckel, V Waldmann and H Näher The human herpesvirus-type 8 is not involved in malignant melanoma doi:10.1038/sj.bjc.6690322 Abstract | Full article | PDF R Hipfel, B Schittek, Y Bodingbauer and C Garbe Specifically regulated genes in malignant melanoma tissues identified by subtractive hybridization doi:10.1054/bjoc.1999.1055 Abstract | Full article | PDF G Palmieri, A Cossu, P A Ascierto, G Botti, M Strazzullo, A Lissia, M Colombino, M Casula, C Floris, F Tanda, M Pirastu and G Castello Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases doi:10.1054/bjoc.2000.1513 Abstract | Full article | PDF A Håkansson, B Gustafsson, L Krysander, B Hjelmqvist, B Rettrup and L Håkansson Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes doi:10.1054/bjoc.2001.2169 Abstract | Full article | PDF |
||||||||
| malignant melanoma of soft parts S M Langezaal, J F Graadt van Roggen, A M Cleton-Jansen, J J Baelde and P C W Hogendoorn Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts) doi:10.1054/bjoc.2000.1628 Abstract | Full article | PDF |
||||||||
| malignant mesothelioma A K Nowak, M J Byrne, R Williamson, G Ryan, A Segal, D Fielding, P Mitchell, A W Musk and B W S Robinson A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma doi:10.1038/sj.bjc.6600505 Abstract | Full article | PDF J G Edwards, J McLaren, J L Jones, D A Waller and K J O'Byrne Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura doi:10.1038/sj.bjc.6600920 Abstract | Full article | PDF M Tomasetti, M R Rippo, R Alleva, S Moretti, L Andera, J Neuzil and A Procopio -Tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells
advance online publication, 2004-03-23 00:00:00.000; doi:10.1038/sj.bjc.6601707 Abstract | Full article | PDF Y Ohta, V Shridhar, R K Bright, G P Kalemkerian, W Du, M Carbone, Y Watanabe and H I Pass VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours doi:10.1038/sj.bjc.6690650 Abstract | Full article | PDF A-M Björkqvist, M Wolf, S Nordling, L Tammilehto, A Knuuttila, J Kere, K Mattson and S Knuutila Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis doi:10.1038/sj.bjc.6690816 Abstract | Full article | PDF Y Li and P Heldin Hyaluronan production increases the malignant properties of mesothelioma cells doi:10.1054/bjoc.2001.1922 Abstract | Full article | PDF J G Edwards, G Cox, A Andi, J L Jones, R A Walker, D A Waller and K J O'Byrne Angiogenesis is an independent prognostic factor in malignant mesothelioma doi:10.1054/bjoc.2001.1997 Abstract | Full article | PDF F Le Pimpec-Barthes, I Bernard, I Abd Alsamad, A Renier, L Kheuang, J Fleury-Feith, P Devauchelle, F Quintin Colonna, M Riquet and M C Jaurand Pleuro-pulmonary tumours detected by clinical and chest X-ray analyses in rats transplanted with mesothelioma cells doi:10.1038/sj.bjc.6693248 Abstract | Full article | PDF |
||||||||
| malignant neoplasms A H Olsen, A Jensen, S H Njor, E Villadsen, W Schwartz, I Vejborg and E Lynge Breast cancer incidence after the start of mammography screening in Denmark doi:10.1038/sj.bjc.6600712 Abstract | Full article | PDF |
||||||||
| malignant pericarditis T Moriya, Y Takiguchi, H Tabeta, R Watanabe, H Kimura, K Nagao and T Kuriyama Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-small-cell lung cancer doi:10.1054/bjoc.2000.1397 Abstract | Full article | PDF |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2008 Cancer Research UK | ||
| |||
| Privacy Policy | |||